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ABSTRACT  
Diabetic retinopathy may induce visual impairment. We evaluated vision-related quality-of-life in 
patients with retinopathy and visual acuity <5/10 in the better eye using the 25-item National Eye 
Institute Visual Functioning Questionnaire (NEI VFQ-25). The NEI VFQ-25 was self-administered 
to 196 patients in 3 Italian centres (A, B and C; n=64, 61 and 71, respectively) dedicated to DR 
screening and treatment. Patients in the 3 centres did not differ by age, gender, occupation and 
diabetes duration. Multivariate analysis demonstrated that reduced visual acuity was associated with 
decreased scores for General Vision, Near Activities, Distance Activities, Visual Specific Social 
Functioning, Mental Health, Role Difficulties and Dependency, Driving, Colour Vision and 
Peripheral Vision (p<0.01, all). Treatment by photocoagulation was associated with reduced scores 
in General Health (-8.3; p=0.002), General Vision (-7.2; p=0.001), Visual Specific Role Difficulties 
(-8.8; p=0.015) and Driving (-13.7; p=0.003). Centre affiliation was associated with different scores 
for General Health, Ocular pain, Distance Activities, Visual Specific Social Functioning and Role 
Difficulties and Peripheral Vision. Women had higher scores for General Vision (p=0.015), Near 
Activities (p=0.005), Distance Activities (p=0.006), Visual Specific Social Functioning (p=0.03), 
Visual Specific Mental Health (p=0.035) and Colour Vision  (p=0.012). Diabetic retinopathy and 
vision loss modify the way people perceive their own ability to function autonomously. More data 
should be collected to confirm this interpretation and to guide the development of more appropriate 
settings to improve approach and support to patients. 
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INTRODUCTION 
Diabetic retinopathy (DR) develops in most people with diabetes and may progress to sight-
threatening stages in some of them (1). Despite all efforts to achieve good control of blood glucose 
(2,3) and blood pressure (4) and active screening for sight-threatening DR (5), some patients may 
suffer serious impairment of their visual function and a consequent decrease in their quality of life 
(6). Vision plays an important role in the ability of people to process information from their 
environment and to participate in everyday activities such as reading, working at home or in the 
office, walking, driving, and interacting with others (7). People with visual impairment may face 
challenges in completing these activities, which in some cases may lead to depression, social 
isolation, and difficulties at home, in school, or at work (8). The 25-item National Eye Institute 
Visual Function Questionnaire (NEI VFQ-25) was developed to measure self-reported, vision-
related aspects of health status that are most significant to individuals with chronic eye disease 
(9,10). In this study we evaluated changes in vision-related quality-of-life in patients with DR and 
impaired vision using the NEI VFQ-25 in 3 Italian centres dedicated to screening and treatment of 
DR.  
 
PATIENTS AND METHODS.  
A validated Italian version of the NEI VFQ-25 (11) was self-administered, between 2007 and 2010, 
to 196 consecutive patients with visual acuity <5/10 (LogMar 0.3) in the better eye, 64 in Centre A, 
61 in Centre B, and 71 in Centre C, on the occasion of routine visits. If the patients had difficulties 
with reading or literacy problems, they were assisted by a trained operator. The study was 
performed following all guidelines for experimental investigations required by the Institutional 
Review Board or Ethics Committee of the institutions to which the authors are affiliated.  Informed 
consent was obtained from the patients and none refused to participate. For each patient we 
collected age, gender, education, work activity, diabetes type, frequency of screening for diabetic 
retinopathy, visual acuity, presence of cataract in one or both eyes and laser treatment in progress 
and /or past. Their main clinical characteristics are shown in Table 1. 
 
Questionnaire 
The NEI VFQ-25 includes 25 items that measure vision-targeted health related quality of life 
(HRQoL) and are grouped into 12 subscales: general health (1 item); general vision (1 item); ocular 
pain (2 items); difficulty with near-vision activities (3 items); difficulty with distance-vision 
activities (3 items); limitations of social functioning due to vision (2 items); mental health problems 
due to vision (4 items), role limitations due to vision (2 items); dependency on others due to vision 
(3 items); driving difficulties (2 items); difficulty with colour vision (1 item); and difficulty with 
peripheral vision (1 item). Each subscale is converted to a score between 0 and 100, where higher 
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scores indicate better vision-specific HRQoL. The composite VFQ-25 score is the mean score of all 
items, except for the general health item. The questionnaire had been translated into Italian and 
validated (11) 
 
Centres 
All Centres provided informative leaflets and displayed wall-mounted posters on DR for their 
patients and had flexible appointment policies but differed in many other respects.  
One centre is in a city of about 1 million inhabitants and performs screening and photocoagulation 
within an Internal Medicine Department. The building is 75 years old. Three rooms, 5 physicians 
and 3 nurses are dedicated to DR screening and laser treatment. This Centre serves diabetes clinics 
and patients from within and outside the Department. No programme is specifically dedicated to 
informing patients about DR and its treatment. The second centre is in a town of about 160,000 
inhabitants and is located in a small building within the ophthalmic department of a 90 year old 
main hospital. Every room is dedicated to a specific eye care activity. Patients are informed about 
DR by the referring diabetologist and looked after by ophthalmic residents. Five ophthalmologists 
perform DR screening and treatment. The third centre is an academic eye clinic in a town with a 
population of about 70 000, which has been collaborating with the local diabetes clinic for many 
years. The hospital is 50 years old but the eye clinic has spacious and bright rooms. Two days a 
week are dedicated to laser treatment and, before each session, a nurse and an ophthalmologist 
inform patients about retinopathy screening and how it is administered. 
 
Statistical analysis 
Descriptive results are shown as absolute frequencies for categorical data and as mean ± SD for 
continuous variables. The chi-square test was used for categorical variables, Analysis of variance 
(ANOVA) with Bonferroni correction, or Kruskal-Wallis test in the case of non-parametric 
distribution, were used for continuous variables in order to assess whether significant differences 
could be detected among the 3 centres. 
Multivariate analysis models were fitted: scores from the different subscales of vision-related 
quality of life were set as dependent variables and age, gender, diabetes type, visual acuity, 
presence of cataract in one or both eyes, severity of retinopathy (4 categories, ranging from 
moderate non-proliferative DR with clinically significant macular edema to severe proliferative 
DR), previous laser treatment and centre affiliation were taken as independent variables. For all 
tests a p-value of less than 0,05 was considered significant. All analyses were performed with Stata 
11. 
 
RESULTS 
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Patients in the 3 centres did not differ by age, gender, occupation or diabetes duration, but did for 
schooling, type of diabetes, cataract status, previous laser treatment and frequency of eye control 
visits (Table 1). 
Multivariate analysis demonstrated that impaired Visual Acuity was associated with lower scores in 
General Vision, Near Activities, Distance Activities, Visual Specific Social Functioning, Visual 
Specific Mental Health, Visual Specific Role Difficulties, Visual Specific Dependency, Driving, 
Color Vision and Peripheral Vision (p<0.01) (Results not shown).  
Previous treatment by laser photocoagulation was associated with lower scores in General Health   
(-8.3; p=0.002), General Vision (-7.2; p=0.001), Visual Specific Role Difficulties (-8.8; p=0.015) 
and Driving (-13.7; p=0.003) scales. 
Centre affiliation was associated with lower scores in General Health (Centre B vs Centre A: -8.5; 
p=0.022) and with differences in Ocular pain, Near-Vision Activities, Distance Activities, Visual 
Specific Social Functioning, Visual Specific Role Difficulties, Visual Specific Dependency, Color 
Vision, and Peripheral Vision, the lowest scores being in Centre C and the highest in Centre B 
(Table 2).  
Women had higher scores for General Vision (p=0.015), Near Activities (p=0.005), Distance 
Activities (p=0.006), Visual Specific Social Functioning (p=0.03), Visual Specific Mental Health 
(p=0.035) and Colour Vision  (p=0.012). 
 
DISCUSSION 
The NEI VFQ-25 was developed from focus groups with patients representing a diverse range of 
visual conditions, with the aim of developing a scale that could be generalized to all patients with 
vision impairments, regardless of the cause (9,10). The Los Angeles Latino Eye Study (LALES) is 
one prominent example where the impact of vision loss on HRQoL was assessed over four years in 
a population cohort (8). The study assessed different conditions, including glaucoma, retinopathy 
and age-related macular degeneration and some of the data were focused on the changes 
experienced by people with diabetic retinopathy. 
In this study, multivariate analysis demonstrated that reduced visual acuity in patients with DR was 
associated with decreased quality of life due to impaired General Vision, Near Activities, Distance 
Activities, Visual Specific Social Functioning, Visual Specific Mental Health, Visual Specific Role 
Difficulties, Visual Specific Dependency, Driving, Colour Vision and Peripheral Vision, and that 
the relevant scores worsened significantly with decreasing visual function. The dimensions  
influenced by the presence of diabetic retinopathy detect fragility in social role in addition to 
dependency in everyday life. Women had better results in some of the subscales, independently of 
the other variables considered, but this result is difficult to interpret on the basis of the data 
available for this study. There were also centre-specific differences with patients in one centre 
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faring better scores than in the other two. The patients in the 3 centres had similar age, gender, 
occupation, diabetes duration and treatment and, although there were some differences in schooling, 
prevalence of cataract and visual acuity, these did not appear to explain the differences in quality of 
life. Different resources devoted to informing patients about DR, its treatment and possible 
consequences did not appear to be associated with quality of life in the patients. 
Previous laser treatment was associated with further worsening in some of the indicators, especially 
those related to general health and vision and everyday activities, such as driving. Possibly, this is a 
consequence of more advanced DR severity, which in turn is associated with increased morbidity 
for cardiovascular and other causes (12). In one study comparing visually impaired individuals with 
and without DM, those with DM reported poorer general health, less satisfaction with physical 
health, and more negative feelings generally (13).  
A study published in 2007 suggested that the VFQ-25 score is decreased to a similar extent in 
patients with type 2 diabetes and DR and patients with age-related macular degeneration and that in 
both conditions it is reduced more than in patients with type 1 diabetes and DR, glaucoma or 
cataract (14). Hariprasad  et al. also reported that people with type 2 diabetes and diabetic macular 
edema have scores similar to patients with age-related macular degeneration (15). This study 
confirms that patients with visual impairment due to DR experience discomfort in everyday life and 
lose autonomy in day-to-day functioning, with loss of ability to perform specific tasks.  
The NEI VFQ-25 had been used in previous clinical studies (16) demonstrating consistency and 
validity to assess the impact of retinopathy on the lives of people with diabetes. Further evidence 
supports the validity and reliability of the NEI VFQ-25 to measure quality of life in Diabetic 
Macular Edema (17). Marella et al. questioned the overall psychometric validity of the 
questionnaire, suggesting that the items grouped under visual functioning and socio-emotional traits 
are its most valid constructs (18). However, despite these limitations, the questionnaire was found 
superior to other tools in assessing vision related quality of life (19) and it was the visual 
functioning and socioemotional traits that came out as most relevant in this survey.  
 
Limitations of this study include a limited sample size, centre selection and the absence of exclusion 
criteria for depression. The latter may be a confounder in the perception of quality of life regardless 
of the presence/absence of retinopathy and its severity. No subanalysis was carried out to 
differentiate between Type 2 and Type 1 diabetes, but the aim was to assess the impact of 
retinopathy in the life of a person with diabetes. 
Studies exploring psychological adjustment in individuals with diabetes and visual impairment (20) 
showed that even people with mild DR express feelings of uncertainty and vulnerability at the 
prospect of vision loss. Similarly to other industrialized countries, the social security system in Italy 
provides free access to eye care services, such as screening, assessment and treatment for diabetic 
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retinopathy, although in many instances visits are carried out on a fee-for-service basis. However, 
health care systems too often underestimate the problems that may arise in the quality of life of 
patients (21), especially in view of the tendency of diabetes to associate with depression (22). The 
projected increasing prevalence of STDR and visual impairment (23) and the associated reduction 
in functional status and independence, will greatly increase the resulting burden of this complication 
of diabetes.  
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Table 1 - Data of patients (absolute frequencies of the different categories or mean ± SD in case of continuous variables) Significance is based on 
chi-square tests among the three centres for categorical variables and ANOVA test for continuous variables. 
 
Total 
(n=196) 
Centre A 
(n=64) 
Centre B 
(n=61) 
Centre C 
(n=71) Significance 
Gender (M/F) 105/91 35/29 27/34 43/28 NS 
Age (years) 69.7 ± 6.6 70.7 ± 6.9 68.9 ± 7.1 69.3 ± 5.8 NS 
Known duration of diabetes  16.3 ± 6.6 17.2 ± 6.9 16.0 ± 7.9 15.9 ± 5.3 NS 
Schoolinga (N/P/M/H/U) 5/126/45/16/4 5/39/18/2/0 0/40/12/6/3 0/47/15/8/1 p=0.020 
Occupationb  (H/R/B/W/T/C)  9/177/4/3/1/2 2/61/0/1/0/0 4/49/3/2/1/2 3/67/1/0/0/0 NS 
Diabetes type (Type 1/Type 2) 11/185 4/60 7/54 0/71 p=0.016 
Glucose-lowering treatmentc (D/H/H+I/I) 1/31/44/120 0/15/12/37 0/8/15/38 1/8/17/45 NS 
Visual Acuity  (≤1/ >1≤2/ >2≤3/ >3≤4/ >4) 13/24/45/40/74 10/6/21/13/14 1/5/11/13/31 2/13/13/14/29 p=0.002 
Cataract (No/1 eye/ both eyes/IOL/NA)  74/29/62/26/5 35/6/15/5/3 17/14/14/16/0 22/9/33/5/2 p<0.000 
Retinopathyd (NPDR/PREP/PDR/DME) 26/12/42/116 25/7/10/22 0/3/0/58 1/2/32/36 p<0.000 
Lasere (N/Y/M/NA) 56/39/97/4 13/5/44/2 15/16/28/2 28/18/25/0 p=0.001 
Last eye check (Last month/Last 6 months/Last Year) 76/100/20 24/27/13 11/47/3 41/26/4 p<0.000 
aN = No formal education, P = Primary school, M = Middle school, H = High school, U = University degree 
bH = Housewife, R = Retired, B = Blue collar worker, W = White collar worker, T =  Teacher,  C = Craftsman 
cD=Diet, H=Hypoglicemic, I=Insulin, N = missing 
dNPDR = mild to moderate non proliferative DR; PREP = severe non proliferative DR (pre-proliferative); PDR = proliferative DR; DME = diabetic macular edema 
eN=Never, Y= in the last Year, M= in the last Month, NA = Not Available 
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Table 2 – NEI VFQ-25 Results (mean ± SD). Significance levels are based on Kruskall-Wallis test among the three centres. 
 
Total 
(n=196) 
Centre A 
(n=64) 
Centre B 
(n=61) 
Centre C 
(n=71) Significance 
GH - general health 51.0 ± 15.8 53.6 ± 17.5 49.5 ± 13.2 49.9 ± 16.1 NS 
GV - general vision 47.7 ± 14.7 46.6 ± 13.2 50.5 ± 15.5 46.3 ± 15.1 NS 
OP - ocular pain 81.3 ± 17.9 85.4 ± 16.3 85.7 ± 16.9 73.9 ± 18.0 p<0.005 
NA - near-vision activities 59.1 ± 25.3 55.4 ± 26.7 67.5 ± 24.3 55.2 ± 23.4 p=0.009 
DA - distance-vision activities 70.4 ± 24.3 73.5 ± 21.4 79.1 ± 21.2 60.2 ± 25.8 p<0.005 
VSSF - Visual Specific Social Functioning  77.8 ± 22.8 78.6 ± 23.5 88.1 ± 16.8 68.3 ± 22.9 p<0.005 
VSMH - Visual Specific Mental Health 55.8 ± 25.1 56.8 ± 22.8 61.6 ± 24.2 50.0 ± 26.7 NS 
VSRD - Visual Specific Role Difficulties 65.0 ± 25.5 64.3 ± 28.8 74.7 ± 22.6 57.3 ± 22.2 p<0.005 
VSD - Visual Specific Dependency 63.4 ± 29.3 62.1 ± 30.8 75.3 ± 27.0 54.5 ± 26.5 p<0.005 
D - Driving 47.8 ± 28.1 49.4 ± 23.5 49.0 ± 36.5 45.3 ± 23.5 NS 
CV - Color Vision 71.8 ± 28.1 66.9 ± 28.9 83.6 ± 24.9 65.9 ± 27.3 p<0.005 
PV - Peripheral Vision 73.3 ± 23.9 73.7 ± 23.5 83.6 ± 19.8 64.17 ± 23.9 p<0.005 
 
